Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

638 recalls, newest first

Class II · Moderate risk

Famotidine Tablets USP 40mg

Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.

Terminated Particulate / foreign matter Aurobindo Pharma USA Inc. NDC 65862-860-99 D-0290-2021
Class II · Moderate risk

Levetiracetam Tablets

Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets.

Terminated Particulate / foreign matter Eywa Pharma INC NDC 71930-063-52 D-0109-2021
Class II · Moderate risk

Lisinopril Tablets USP

Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68001-334-08 D-1413-2020
Class II · Moderate risk

Clozapine Tablets USP tablet

Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.

Terminated Particulate / foreign matter Aurobindo Pharma USA Inc. NDC 65862-846-05 D-1370-2020
Class III · Low risk

Lamotrigine Tablets

Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

Terminated Particulate / foreign matter Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-247-97 D-1281-2020
Class II · Moderate risk

Estradiol

cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.

Terminated Particulate / foreign matter B & B Pharmaceuticals, Inc. NDC 63275-9900-8 D-1244-2020
Class II · Moderate risk

Lisinopril Tablets USP

Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-982-01 D-1079-2020
Class III · Low risk

Tacrolimus Capsules

Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.

Terminated Particulate / foreign matter Mylan Pharmaceuticals Inc. NDC 0378-2047-01 D-1057-2020

Recalls by year